Carrier Screening Market Size, Share, Industry Trends and Forecast to 2030

1. Market Size & CAGR of Carrier Screening Market in 2021:

The global carrier screening market is estimated to have a market size of USD 2.5 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 10.3% from 2021 to 2028. The increasing awareness about genetic disorders and the rising demand for early detection and prevention are driving the growth of the carrier screening market.

2. COVID-19 Impact on the Carrier Screening Market:

The COVID-19 pandemic has had a mixed impact on the carrier screening market. On one hand, the focus on healthcare systems and genetic testing has increased, leading to a surge in demand for carrier screening services. However, the restrictions on healthcare services and supply chain disruptions have posed challenges for market growth.

3. Carrier Screening Dynamics:

The carrier screening market is influenced by factors such as technological advancements in genetic testing, increasing prevalence of genetic disorders, growing awareness about carrier screening, and evolving healthcare infrastructure. Market players are focusing on developing innovative screening methods and expanding their product portfolios to gain a competitive edge.

4. Segments and Related Analysis:

The carrier screening market can be segmented based on technology, type of genetic disorder, end-user, and region. By technology, the market is divided into sequencing technologies, PCR-based methods, and other technologies. Based on the type of genetic disorder, the market includes autosomal recessive disorders, X-linked disorders, and others.

5. By Region Analysis:

Regionally, North America holds the largest share of the carrier screening market, followed by Europe and Asia-Pacific. The presence of established healthcare infrastructure, favorable reimbursement policies, and increasing investments in research and development contribute to the dominance of these regions in the carrier screening market.

6. Key Market Players and Competitive Landscape:

Some of the key players in the carrier screening market include Myriad Genetics, Natera Inc., Invitae Corporation, Quest Diagnostics, and Eurofins Scientific. These companies focus on strategic collaborations, product launches, and acquisitions to strengthen their market position and expand their customer base.

7. Recent Happenings in the Carrier Screening Market:

- In August 2021, Myriad Genetics launched a new carrier screening test for cystic fibrosis and spinal muscular atrophy. - In June 2021, Natera Inc. announced the expansion of its carrier screening portfolio with the addition of new genetic tests. - In April 2021, Quest Diagnostics introduced a comprehensive carrier screening test for cystic fibrosis and other genetic disorders. - In January 2021, Eurofins Scientific acquired PerkinElmer's immunodiagnostic business to strengthen its position in the carrier screening market.